Sort
64,565 grants matching “drug discovery”
Discoveries in ADHD genomics: Help or hype in clinical settings?
$772,666Alysa E Doyle · Massachusetts General Hospital · R01 · FY2019 · MH
Understanding causal mechanisms in preeclampsia through genetic instrumental variables
$772,638Ayush Giri · Vanderbilt University Medical Center · R01 · FY2023 · HL
Barcoded nucleosomes for analyzing combinatorial epigenetic regulators
$772,561Zu-Wen Sun · Epicypher, Inc. · R44 · FY2017 · GM
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
$772,551James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2021 · AI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$772,488William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2015 · GM
Nicotinic Ligands for Smoking Cessation
$772,478Henry A. Lester · California Institute Of Technology · U19 · FY2012 · DA
DCTD Functional Genomics
$772,455David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Development of small molecule activators of glutamate transporter EAAT2 for treatment of Alzheimer's disease
$772,430Chien-Liang Glenn Lin · Ohio State University · U01 · FY2017 · AG
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses
$772,406Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2015 · HL
Antisense oligonucleotide treatment for myotonic dystrophy
$772,323Charles A Thornton · University Of Rochester · U01 · FY2014 · NS
Imaging the Invisible with No Labels: A Major Opportunity in Biology and Medicine
$772,311Xiaoliang Sunney Xie · Harvard University · R01 · FY2011 · EB
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$772,307Afshin Dowlati · Case Western Reserve University · U01 · FY2009 · CA
Physiological and therapeutic effects of ANGPTL3 variants in mice and humans
$772,302Marina Cuchel · University Of Pennsylvania · R01 · FY2021 · HL
Predicting Post-Covid Pulmonary Fibrosis with Explainable Deep Learning and Optimal Biomarker Discovery
$772,290Ulas Bagci · Northwestern University At Chicago · R01 · FY2024 · HL
Genetic Determinants of Epilepsy in Murine Systems
$772,289Wayne N. Frankel · Columbia University Health Sciences · R37 · FY2016 · NS
Genetic Determinants of Epilepsy in Murine Systems
$772,289Wayne N. Frankel · Columbia University Health Sciences · R37 · FY2017 · NS
Mechanosensitive ion channels and cortical mechanics
$772,261Frederick Sachs · State University Of New York At Buffalo · R01 · FY2014 · HL
Expanding the druggable genome
$772,200Stephen W. Fesik · Vanderbilt University · DP1 · FY2012 · CA
Expanding the druggable genome
$772,200Stephen W. Fesik · Vanderbilt University · DP1 · FY2011 · OD
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2014 · MH
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2011 · OD
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2012 · MH
N-CANDA: Data Analysis Component
$772,199Adolf Pfefferbaum · Sri International · U01 · FY2014 · AA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
$772,180Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Subtype-selective NMDA ligands for Alzheimer's Disease
$772,160Steven H Liang · Emory University · R01 · FY2024 · AG